Skip to main content

Leadership development at Chery Jaguar Land Rover

行业
Transport
关于

Established in November 2012, Chery Jaguar Land Rover Automotive Co., Ltd. is a 50:50 independent joint venture formed between Chinese auto manufacturer Chery Automobile Co., Ltd. and UK auto manufacturer Jaguar Land Rover.


CJLR Senior Managers were on their development journey to:

  • Enhance Business Result through Development
  • Create Opportunities for Participants to Practice Skills
  • Start to Build Learning Culture for the Organization
  • Ensure the connectivity with Senior Leaders throughout the Development Journey
  • Build Stronger Network among Participants

The CJLR Senior Manager development journey in particular was not set up as a ‘traditional’ management development program but aimed at maintaining a very close connection to CJLR’s core value and business opportunities in China, hence including internal management presentations adjacent to business projects, as well as relevant coaching and peer learnings.

客户评价
了解客户对我们的评价
Participant
calder stewart
“I absolutely loved this module, it created a lot of opportunities for learning and some really great discussions. As a group, it gave us a lot of insight into our strengths and development areas.”
Sophie Smith
APAC HR Director
Experian
“It was a pleasure partnering with Impact. Their knowledge, expertise and passion for development in the great outdoors was superb. Our delegates got huge amounts of value from their jungle experience in Laos, creating life long learning and friendships. We look forward to working with Impact in the future.”
Justyna Jedlińska
Employee Development Manager
Polpharma
“The programme has been tailored the way that we were able to check its effectiveness.
The results of the review confirmed that the number of managers who present strategic and developing styles increased by over 20%. Moreover, the programme had a very positive impact on the inter-departmental / cross-functional cooperation, which is very important in such a large and diverse company as Polpharma."